The Global Coalition on Aging (GCOA) today released a startling new paper, Wonder Drugs vs. Superbugs: The 21st Century Battle to Save 10 Million Lives a Year, which clearly lays out the global threat posed by rising drug resistance, widely known as antimicrobial resistance or AMR, and accompanying lack of effective new drugs.

During World Antimicrobial Awareness Week (WAAW), the Global Coalition on Aging (GCOA) hosted a live webinar and expert panel discussion, sponsored by Merck, titled, AMR Threat to National Health Systems and Economies: A Call-to-Action. The discussion centered around two recently published reports: the 2021 AMR Preparedness Index, a first-of-its-kind report created in partnership with the…

FT dashboard tracks responses to the growing threat of antimicrobial resistance

Five years ago, the UN General Assembly adopted a landmark declaration urging global action against growing anti­microbial resistance (AMR) — which many still view as one of the greatest threats to public health in the 21st century.

New legislation in the United States Congress is usually a routine occurrence, not a seminal event. But the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, or PASTEUR, Act is different.